Abstract
This study evaluated patients with varicose veins treated with sclerotherapy to determine whether adding a venoactive drug (sulodexide) to the standard treatment protocol can reduce the presence of postsclerotherapy hyperpigmentation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have